WallStSmart
TRIB

Trinity Biotech plc

NASDAQ: TRIB · HEALTHCARE · MEDICAL DEVICES

$0.60
+0.00% today

Updated 2026-04-30

Market cap
$12.18M
P/E ratio
P/S ratio
0.25x
EPS (TTM)
$-1.60
Dividend yield
52W range
$1 – $2
Volume
0.2M

WallStSmart proprietary scores

27
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F
5.0
Quality
C+
2.0
Profitability
F
7.0
Valuation
B+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$3.00
+400.00%
12-Month target
Intrinsic (DCF)
$5.52
Margin of safety
+85.09%

Price chart

X-Ray snapshot

Strengths
+ 85.09% below intrinsic value
Risks
- Thin margins at -75.90%
- Negative free cash flow $-77109.00
- Revenue declining -5.50% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$81.15M$62.52M$56.83M$61.55M$48.57M
Net income$875000.00$-41.00M$-24.02M$-31.79M$-5.11M
EPS$-1.60
Free cash flow$4.55M$-6.90M$-12.36M$-14.26M$-77109.00
Profit margin1.08%-65.58%-42.26%-51.64%-75.90%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
TRIB$12.18M272.02.07.05.0+85.09%Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Trinity Biotech plc trades at $0.60. Our Smart Value Score of 27/100 indicates the stock is weak. TTM revenue stands at $48.57M. with profit margins at -75.90%. Our DCF model estimates intrinsic value at $5.52.

Frequently asked questions

What is Trinity Biotech plc's stock price?
Trinity Biotech plc (TRIB) trades at $0.60.
Is Trinity Biotech plc overvalued?
Smart Value Score 27/100 (Grade F, Strong Sell). DCF value $5.52.
What is the price target of Trinity Biotech plc (TRIB)?
The analyst target price is $3.00, representing +400.0% upside from the current price of $0.60.
What is the intrinsic value of Trinity Biotech plc (TRIB)?
Based on our DCF model, intrinsic value is $5.52, a +85.1% margin of safety versus $0.60.
What is Trinity Biotech plc's revenue?
TTM revenue is $48.57M.

Company info

SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.25x
ROE-1,913.00%
Beta0.79
50D MA$0.68
200D MA$0.91
Shares out0.02B
Float0.29B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years